Arnab K. Chatterjee - Publications

Affiliations: 
Calibr 
Area:
Med chem, organic synthesis

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Gupta AK, Pedroarena J, Nazarian A, Antonova-Koch J, Weiss F, Kumpornsin K, Chi V, Woods AK, Lee KJ, Joseph SB, Li S, Brittain J, De Hostos E, Duffy J, Cooper A, ... ... Chatterjee AK, et al. Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemoprevention. Biorxiv : the Preprint Server For Biology. PMID 39005341 DOI: 10.1101/2024.07.01.601566  0.58
2024 Gupta AK, Eliasen AM, Andahazy W, Zhou F, Henson K, Chi V, Woods AK, Joseph SB, Kuhen KL, Wisler J, Ramachandruni H, Duffy J, Burrows JN, Vadas E, Slade A, ... ... Chatterjee AK, et al. A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection. Biorxiv : the Preprint Server For Biology. PMID 38979188 DOI: 10.1101/2024.02.08.579395  0.595
2024 Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, Burgstaller-Muehlbacher S, De Jesus PD, Teriete P, Hull MV, Chang MW, Chan JF, Cao J, Poon VK, Herbert KM, ... ... Chatterjee AK, et al. Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. PMID 38890463 DOI: 10.1038/s41586-024-07659-8  0.509
2024 Elshan NGRD, Wolff KC, Riva L, Woods AK, Grabovyi G, Wilson K, Pedroarena J, Ghorai S, Nazarian A, Weiss F, Liu Y, Mazumdar W, Song L, Okwor N, Malvin J, ... ... Chatterjee AK, et al. Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead". Journal of Medicinal Chemistry. PMID 38875353 DOI: 10.1021/acs.jmedchem.4c01269  0.752
2024 Shao S, Zhang N, Specht GP, You S, Song L, Fu Q, Huang D, You H, Shu J, Domissy A, Li S, Nguyen-Tran V, Joseph SB, Chatterjee AK, Chen JJ, et al. Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair. Proceedings of the National Academy of Sciences of the United States of America. 121: e2400077121. PMID 38598345 DOI: 10.1073/pnas.2400077121  0.505
2024 Dayan Elshan NGR, Wolff KC, Riva L, Woods AK, Grabovyi G, Wilson K, Pedroarena J, Ghorai S, Nazarian A, Weiss F, Liu Y, Mazumdar W, Song L, Okwor N, Malvin J, ... ... Chatterjee AK, et al. Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead. Journal of Medicinal Chemistry. PMID 38335279 DOI: 10.1021/acs.jmedchem.3c01938  0.762
2023 Grzelak EM, Elshan NGRD, Shao S, Bulos ML, Joseph SB, Chatterjee AK, Chen JJ, Nguyên-Trân V, Schultz PG, Bollong MJ. Pharmacological YAP activation promotes regenerative repair of cutaneous wounds. Proceedings of the National Academy of Sciences of the United States of America. 120: e2305085120. PMID 37399395 DOI: 10.1073/pnas.2305085120  0.487
2023 Ko Y, Hong M, Lee S, Kumar M, Ibrahim L, Nutsch K, Stanton C, Sondermann P, Sandoval B, Bulos ML, Iaconelli J, Chatterjee AK, Wiseman RL, Schultz PG, Bollong MJ. S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. Proceedings of the National Academy of Sciences of the United States of America. 120: e2300763120. PMID 37155889 DOI: 10.1073/pnas.2300763120  0.503
2022 Oh CK, Nakamura T, Beutler N, Zhang X, Piña-Crespo J, Talantova M, Ghatak S, Trudler D, Carnevale LN, McKercher SR, Bakowski MA, Diedrich JK, Roberts AJ, Woods AK, Chi V, ... ... Chatterjee AK, et al. Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection. Nature Chemical Biology. PMID 36175661 DOI: 10.1038/s41589-022-01149-6  0.425
2022 Oh CK, Nakamura T, Beutler N, Zhang X, Piña-Crespo J, Talantova M, Ghatak S, Trudler D, Carnevale LN, McKercher SR, Bakowski MA, Diedrich JK, Roberts AJ, Woods AK, Chi V, ... ... Chatterjee AK, et al. Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection. Biorxiv : the Preprint Server For Biology. PMID 35411336 DOI: 10.1101/2022.04.05.487060  0.424
2022 Radke JB, Melillo B, Mittal P, Sharma M, Sharma A, Fu Y, Uddin T, Gonse A, Comer E, Schreiber SL, Gupta AK, Chatterjee AK, Sibley LD. Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase. Nature Communications. 13: 459. PMID 35075105 DOI: 10.1038/s41467-022-28108-y  0.406
2021 Bakowski MA, Beutler N, Wolff KC, Kirkpatrick MG, Chen E, Nguyen TH, Riva L, Shaabani N, Parren M, Ricketts J, Gupta AK, Pan K, Kuo P, Fuller M, Garcia E, ... ... Chatterjee AK, et al. Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature Communications. 12: 3309. PMID 34083527 DOI: 10.1038/s41467-021-23328-0  0.64
2021 Shalhout SZ, Yang PY, Grzelak EM, Nutsch K, Shao S, Zambaldo C, Iaconelli J, Ibrahim L, Stanton C, Chadwick SR, Chen E, DeRan M, Li S, Hull M, Wu X, ... Chatterjee AK, et al. YAP-dependent proliferation by a small molecule targeting annexin A2. Nature Chemical Biology. PMID 33723431 DOI: 10.1038/s41589-021-00755-0  0.524
2021 Jo J, Ibrahim L, Iaconelli J, Kwak J, Kumar M, Jung Y, Lairson LL, Chatterjee AK, Schultz PG, Bollong MJ, Yun H. Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators. Bioorganic Chemistry. 108: 104614. PMID 33508678 DOI: 10.1016/j.bioorg.2020.104614  0.535
2020 Chin EN, Yu C, Vartabedian VF, Jia Y, Kumar M, Gamo AM, Vernier W, Ali SH, Kissai M, Lazar DC, Nguyen N, Pereira LE, Benish B, Woods AK, Joseph SB, ... ... Chatterjee AK, et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science (New York, N.Y.). 369: 993-999. PMID 32820126 DOI: 10.1126/Science.Abb4255  0.58
2020 Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Pache L, Burgstaller-Muehlbacher S, De Jesus PD, Teriete P, Hull MV, Chang MW, Chan JF, Cao J, Poon VK, Herbert KM, ... ... Chatterjee AK, et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. PMID 32707573 DOI: 10.1038/S41586-020-2577-1  0.606
2020 Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Burgstaller-Muehlbacher S, Pache L, De Jesus PP, Hull MV, Chang M, Chan JF, Cao J, Poon VK, Herbert K, Nguyen TT, ... ... Chatterjee AK, et al. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. Biorxiv : the Preprint Server For Biology. PMID 32511357 DOI: 10.1101/2020.04.16.044016  0.555
2020 Zambaldo C, Vinogradova EV, Qi X, Iaconelli J, Suciu RM, Koh M, Senkane K, Chadwick SR, Sanchez BB, Chen JS, Chatterjee AK, Liu P, Schultz PG, Cravatt BF, Bollong MJ. 2-Sulfonyl pyridines as tunable, cysteine-reactive electrophiles. Journal of the American Chemical Society. PMID 32302104 DOI: 10.1021/Jacs.0C02721  0.609
2020 Johnson K, Woods A, Joseph S, Chatterjee A, Zhu S, Wisler J, Klyushnichenko V, Li J, Lotz M, Tremblay M, Schultz P. Development of KA34 as a cartilage regenerative therapy for Osteoarthritis Osteoarthritis and Cartilage. 28: S518. DOI: 10.1016/J.Joca.2020.02.814  0.502
2019 Ardestani A, Li S, Annamalai K, Lupse B, Geravandi S, Dobrowolski A, Yu S, Zhu S, Baguley TD, Surakattula M, Oetjen J, Hauberg-Lotte L, Herranz R, Awal S, Altenhofen D, ... ... Chatterjee AK, et al. Neratinib protects pancreatic beta cells in diabetes. Nature Communications. 10: 5015. PMID 31676778 DOI: 10.1038/S41467-019-12880-5  0.541
2019 Kim YJ, Cubitt B, Chen E, Hull MV, Chatterjee AK, Cai Y, Kuhn JH, de la Torre JC. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors. Antiviral Research. 104558. PMID 31302150 DOI: 10.1016/J.Antiviral.2019.104558  0.355
2019 Bakowski MA, Shiroodi RK, Liu R, Olejniczak J, Yang B, Gagaring K, Guo H, White PM, Chappell L, Debec A, Landmann F, Dubben B, Lenz F, Struever D, Ehrens A, ... ... Chatterjee AK, et al. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections. Science Translational Medicine. 11. PMID 31068442 DOI: 10.1126/Scitranslmed.Aav3523  0.583
2018 Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, Chin EN, Ahmad I, Chatterjee AK, Lairson LL, Schultz PG, Moellering RE. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. PMID 30323285 DOI: 10.1038/S41586-018-0622-0  0.551
2018 Janes J, Young ME, Chen E, Rogers NH, Burgstaller-Muehlbacher S, Hughes LD, Love MS, Hull MV, Kuhen KL, Woods AK, Joseph SB, Petrassi HM, McNamara CW, Tremblay MS, Su AI, ... ... Chatterjee AK, et al. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proceedings of the National Academy of Sciences of the United States of America. 115: 10750-10755. PMID 30282735 DOI: 10.1073/Pnas.1810137115  0.597
2018 Miglianico M, Eldering M, Slater H, Ferguson N, Ambrose P, Lees RS, Koolen KMJ, Pruzinova K, Jancarova M, Volf P, Koenraadt CJM, Duerr HP, Trevitt G, Yang B, Chatterjee AK, et al. Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases. Proceedings of the National Academy of Sciences of the United States of America. PMID 29967151 DOI: 10.1073/Pnas.1801338115  0.554
2018 Zhang G, Baidin V, Pahil KS, Moison E, Tomasek D, Ramadoss NS, Chatterjee AK, McNamara CW, Young TS, Schultz PG, Meredith TC, Kahne D. Cell-based screen for discovering lipopolysaccharide biogenesis inhibitors. Proceedings of the National Academy of Sciences of the United States of America. PMID 29735709 DOI: 10.1073/Pnas.1804670115  0.554
2018 Harbut MB, Liu R, Yang B, Yano T, Vilcheze C, Lockner J, Guo H, Franzblau SG, Petrassi M, Jacobs WR, Rubin H, Chatterjee AK, Wang F. Small molecules targeting Mycobacterium tuberculosis type II NADH dehydrogenase with antimycobacterial activity. Angewandte Chemie (International Ed. in English). PMID 29388301 DOI: 10.1002/Anie.201800260  0.353
2017 Choi SH, Mahankali M, Lee SJ, Hull M, Petrassi HM, Chatterjee AK, Schultz PG, Jones KA, Shen W. Targeted disruption of Myc-Max oncoprotein complex by a small molecule. Acs Chemical Biology. PMID 28976731 DOI: 10.1021/Acschembio.7B00799  0.563
2017 Bollong MJ, Yang B, Vergani N, Beyer BA, Chin EN, Zambaldo C, Wang D, Chatterjee AK, Lairson LL, Schultz PG. Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis. Proceedings of the National Academy of Sciences of the United States of America. 114: 4679-4684. PMID 28416697 DOI: 10.1073/Pnas.1702750114  0.568
2017 Bouvard C, Lim SM, Ludka J, Yazdani N, Woods AK, Chatterjee AK, Schultz PG, Zhu S. Small molecule selectively suppresses MYC transcription in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 114: 3497-3502. PMID 28292893 DOI: 10.1073/Pnas.1702663114  0.544
2017 Love MS, Beasley FC, Jumani RS, Wright TM, Chatterjee AK, Huston CD, Schultz PG, McNamara CW. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. Plos Neglected Tropical Diseases. 11: e0005373. PMID 28158186 DOI: 10.1371/Journal.Pntd.0005373  0.609
2016 Wang RE, Wang Y, Zhang Y, Gabrelow C, Zhang Y, Chi V, Fu Q, Luo X, Wang D, Joseph S, Johnson K, Chatterjee AK, Wright TM, Nguyen-Tran VT, Teijaro J, et al. Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant. Proceedings of the National Academy of Sciences of the United States of America. 113: 11501-11506. PMID 27663736 DOI: 10.1073/Pnas.1612803113  0.537
2016 Staus DP, Strachan RT, Manglik A, Pani B, Kahsai AW, Kim TH, Wingler LM, Ahn S, Chatterjee A, Masoudi A, Kruse AC, Pardon E, Steyaert J, Weis WI, Prosser RS, et al. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation. Nature. PMID 27409812 DOI: 10.1038/Nature18636  0.679
2015 Khare S, Roach SL, Barnes SW, Hoepfner D, Walker JR, Chatterjee AK, Neitz RJ, Arkin MR, McNamara CW, Ballard J, Lai Y, Fu Y, Molteni V, Yeh V, McKerrow JH, et al. Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease. Plos Pathogens. 11: e1005058. PMID 26186534 DOI: 10.1371/Journal.Ppat.1005058  0.33
2015 Lim RK, Yu S, Cheng B, Li S, Kim NJ, Cao Y, Chi V, Kim JY, Chatterjee AK, Schultz PG, Tremblay MS, Kazane SA. Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate. Bioconjugate Chemistry. 26: 2216-22. PMID 25945727 DOI: 10.1021/Acs.Bioconjchem.5B00203  0.576
2015 Harbut MB, Vilchèze C, Luo X, Hensler ME, Guo H, Yang B, Chatterjee AK, Nizet V, Jacobs WR, Schultz PG, Wang F. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 112: 4453-8. PMID 25831516 DOI: 10.1073/Pnas.1504022112  0.569
2015 Flannery EL, McNamara CW, Kim SW, Kato TS, Li F, Teng CH, Gagaring K, Manary MJ, Barboa R, Meister S, Kuhen K, Vinetz JM, Chatterjee AK, Winzeler EA. Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. Acs Chemical Biology. 10: 413-20. PMID 25322084 DOI: 10.1021/Cb500616X  0.314
2015 Neitz RJ, Chen S, Supek F, Yeh V, Kellar D, Gut J, Bryant C, Gallardo-Godoy A, Molteni V, Roach SL, Khare S, Stinson M, Chatterjee AK, Robertson S, Renslo AR, et al. Lead identification to clinical candidate selection: drugs for Chagas disease. Journal of Biomolecular Screening. 20: 101-11. PMID 25281737 DOI: 10.1177/1087057114553103  0.339
2014 Vaidya AB, Morrisey JM, Zhang Z, Das S, Daly TM, Otto TD, Spillman NJ, Wyvratt M, Siegl P, Marfurt J, Wirjanata G, Sebayang BF, Price RN, Chatterjee A, Nagle A, et al. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum. Nature Communications. 5: 5521. PMID 25422853 DOI: 10.1038/Ncomms6521  0.324
2014 Kuhen KL, Chatterjee AK, Rottmann M, Gagaring K, Borboa R, Buenviaje J, Chen Z, Francek C, Wu T, Nagle A, Barnes SW, Plouffe D, Lee MC, Fidock DA, Graumans W, et al. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrobial Agents and Chemotherapy. 58: 5060-7. PMID 24913172 DOI: 10.1128/Aac.02727-13  0.438
2014 Zeeman AM, van Amsterdam SM, McNamara CW, Voorberg-van der Wel A, Klooster EJ, van den Berg A, Remarque EJ, Plouffe DM, van Gemert GJ, Luty A, Sauerwein R, Gagaring K, Borboa R, Chen Z, Kuhen K, ... ... Chatterjee AK, et al. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro. Antimicrobial Agents and Chemotherapy. 58: 1586-95. PMID 24366744 DOI: 10.1128/Aac.01927-13  0.316
2014 Tatipaka HB, Gillespie JR, Chatterjee AK, Norcross NR, Hulverson MA, Ranade RM, Nagendar P, Creason SA, McQueen J, Duster NA, Nagle A, Supek F, Molteni V, Wenzler T, Brun R, et al. Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis. Journal of Medicinal Chemistry. 57: 828-35. PMID 24354316 DOI: 10.1021/Jm401178T  0.362
2014 Flannery EL, Chatterjee AK, Winzeler EA. Erratum: Antimalarial drug discovery — approaches and progress towards new medicines Nature Reviews Microbiology. 12: 70-70. DOI: 10.1038/Nrmicro3183  0.314
2013 Yokokawa F, Wang G, Chan WL, Ang SH, Wong J, Ma I, Rao SP, Manjunatha U, Lakshminarayana SB, Herve M, Kounde C, Tan BH, Thayalan P, Ng SH, Nanjundappa M, ... ... Chatterjee AK, et al. Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents. Acs Medicinal Chemistry Letters. 4: 451-5. PMID 24900693 DOI: 10.1021/Ml400071A  0.368
2013 Rao SP, Lakshminarayana SB, Kondreddi RR, Herve M, Camacho LR, Bifani P, Kalapala SK, Jiricek J, Ma NL, Tan BH, Ng SH, Nanjundappa M, Ravindran S, Seah PG, Thayalan P, ... ... Chatterjee AK, et al. Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. Science Translational Medicine. 5: 214ra168. PMID 24307692 DOI: 10.1126/Scitranslmed.3007355  0.333
2013 McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ, Zeeman AM, Dechering KJ, Kumar TS, Henrich PP, Gagaring K, et al. Targeting Plasmodium PI(4)K to eliminate malaria. Nature. 504: 248-253. PMID 24284631 DOI: 10.1038/Nature12782  0.313
2013 Flannery EL, Chatterjee AK, Winzeler EA. Antimalarial drug discovery - approaches and progress towards new medicines. Nature Reviews. Microbiology. 11: 849-62. PMID 24217412 DOI: 10.1038/Nrmicro3138  0.329
2013 Kondreddi RR, Jiricek J, Rao SP, Lakshminarayana SB, Camacho LR, Rao R, Herve M, Bifani P, Ma NL, Kuhen K, Goh A, Chatterjee AK, Dick T, Diagana TT, Manjunatha UH, et al. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents. Journal of Medicinal Chemistry. 56: 8849-59. PMID 24090347 DOI: 10.1021/Jm4012774  0.366
2013 Chatterjee AK. Cell-based medicinal chemistry optimization of high-throughput screening (HTS) hits for orally active antimalarials. Part 1: challenges in potency and absorption, distribution, metabolism, excretion/pharmacokinetics (ADME/PK). Journal of Medicinal Chemistry. 56: 7741-9. PMID 23927720 DOI: 10.1021/Jm400314M  0.352
2013 Wang F, Sambandan D, Halder R, Wang J, Batt SM, Weinrick B, Ahmad I, Yang P, Zhang Y, Kim J, Hassani M, Huszar S, Trefzer C, Ma Z, Kaneko T, ... ... Chatterjee AK, et al. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 110: E2510-7. PMID 23776209 DOI: 10.1073/Pnas.1309171110  0.599
2013 Ramadoss NS, Alumasa JN, Cheng L, Wang Y, Li S, Chambers BS, Chang H, Chatterjee AK, Brinker A, Engels IH, Keiler KC. Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activity. Proceedings of the National Academy of Sciences of the United States of America. 110: 10282-7. PMID 23733947 DOI: 10.1073/Pnas.1302816110  0.358
2013 Wang F, Sambandan D, Halder R, Wang J, Batt SM, Weinrick B, Ahmad I, Yang P, Zhang Y, Kim J, Hassani M, Huszar S, Trefzer C, Ma Z, Kaneko T, ... ... Chatterjee AK, et al. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis (vol 110, pg E2510, 2013) Proceedings of the National Academy of Sciences of the United States of America. 110: 15848-15848. DOI: 10.1073/Pnas.1315914110  0.538
2013 Wang F, Sambandan D, Halder R, Wang J, Batt SM, Weinrick B, Ahmad I, Yang P, Zhang Y, Kim J, Hassani M, Huszar S, Trefzer C, Ma Z, Kaneko T, ... ... Chatterjee AK, et al. Erratum: Identification of a small molecule with activity against drug-resistant and persistent tuberculosis (Proceedings of the National Academy of Sciences of the United States of America (2013) 27:110 (E2510-E2517)) Proceedings of the National Academy of Sciences of the United States of America. 110. DOI: 10.1073/Pnas.1314629110  0.54
2012 Nagle A, Wu T, Kuhen K, Gagaring K, Borboa R, Francek C, Chen Z, Plouffe D, Lin X, Caldwell C, Ek J, Skolnik S, Liu F, Wang J, Chang J, ... ... Chatterjee AK, et al. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. Journal of Medicinal Chemistry. 55: 4244-73. PMID 22524250 DOI: 10.1021/Jm300041E  0.398
2012 Mak PA, Rao SP, Ping Tan M, Lin X, Chyba J, Tay J, Ng SH, Tan BH, Cherian J, Duraiswamy J, Bifani P, Lim V, Lee BH, Ling Ma N, Beer D, ... ... Chatterjee A, et al. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis. Acs Chemical Biology. 7: 1190-7. PMID 22500615 DOI: 10.1021/Cb2004884  0.337
2012 Chatterjee AK, Yeung BK. Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials. Current Topics in Medicinal Chemistry. 12: 473-83. PMID 22242845 DOI: 10.2174/156802612799362977  0.313
2011 Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, ... ... Chatterjee A, et al. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science (New York, N.Y.). 334: 1372-7. PMID 22096101 DOI: 10.1126/Science.1211936  0.619
2011 Wu T, Nagle A, Kuhen K, Gagaring K, Borboa R, Francek C, Chen Z, Plouffe D, Goh A, Lakshminarayana SB, Wu J, Ang HQ, Zeng P, Kang ML, Tan W, ... ... Chatterjee AK, et al. Imidazolopiperazines: hit to lead optimization of new antimalarial agents. Journal of Medicinal Chemistry. 54: 5116-30. PMID 21644570 DOI: 10.1021/Jm2003359  0.436
2011 Wu T, Nagle AS, Chatterjee AK. Road towards new antimalarials - overview of the strategies and their chemical progress. Current Medicinal Chemistry. 18: 853-71. PMID 21182479 DOI: 10.2174/092986711794927748  0.417
2011 Crowther GJ, Napuli AJ, Gilligan JH, Gagaring K, Borboa R, Francek C, Chen Z, Dagostino EF, Stockmyer JB, Wang Y, Rodenbough PP, Castaneda LJ, Leibly DJ, Bhandari J, Gelb MH, ... ... Chatterjee AK, et al. Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. Molecular and Biochemical Parasitology. 175: 21-9. PMID 20813141 DOI: 10.1016/J.Molbiopara.2010.08.005  0.374
2010 Pethe K, Sequeira PC, Agarwalla S, Rhee K, Kuhen K, Phong WY, Patel V, Beer D, Walker JR, Duraiswamy J, Jiricek J, Keller TH, Chatterjee A, Tan MP, Ujjini M, et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nature Communications. 1: 57. PMID 20975714 DOI: 10.1038/Ncomms1060  0.323
2010 Deng X, Nagle A, Wu T, Sakata T, Henson K, Chen Z, Kuhen K, Plouffe D, Winzeler E, Adrian F, Tuntland T, Chang J, Simerson S, Howard S, Ek J, ... ... Chatterjee AK, et al. Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials. Bioorganic & Medicinal Chemistry Letters. 20: 4027-31. PMID 20610151 DOI: 10.1016/J.Bmcl.2010.05.095  0.43
2010 Chatterjee AK, Toste FD, Choi T, Grubbs RH. ChemInform Abstract: Ruthenium-Catalyzed Olefin Cross Metathesis of Styrenes as an Alternative to the Heck and Cross-Coupling Reactions. Cheminform. 33: no-no. DOI: 10.1002/chin.200252055  0.667
2010 Chatterjee AK, Sanders DP, Grubbs RH. ChemInform Abstract: Synthesis of Symmetrical Trisubstituted Olefins by Cross Metathesis. Cheminform. 33: no-no. DOI: 10.1002/chin.200242069  0.602
2010 Choi T, Lee CW, Chatterjee AK, Grubbs RH. ChemInform Abstract: Olefin Metathesis Involving Ruthenium Enoic Carbene Complexes. Cheminform. 33: no-no. DOI: 10.1002/chin.200207056  0.562
2010 Chatterjee AK, Choi T, Grubbs RH. ChemInform Abstract: Synthesis of Vinyl- and Allylphosphonates by Olefin Cross-Metathesis. Cheminform. 32: no-no. DOI: 10.1002/chin.200142199  0.609
2010 Choi T, Chatterjee AK, Grubbs RH. ChemInform Abstract: Synthesis of α,β-Unsaturated Amides by Olefin Cross-Metathesis. Cheminform. 32: no-no. DOI: 10.1002/chin.200129085  0.585
2010 Chatterjee AK, Morgan JP, Scholl M, Grubbs RH. ChemInform Abstract: Synthesis of Functionalized Olefins by Cross and Ring-Closing Metatheses. Cheminform. 31: no-no. DOI: 10.1002/chin.200030066  0.381
2010 Blackwell HE, O'Leary DJ, Chatterjee AK, Washenfelder RA, Bussmann DA, Grubbs RH. ChemInform Abstract: New Approaches to Olefin Cross-Metathesis. Cheminform. 31: no-no. DOI: 10.1002/chin.200015061  0.586
2010 Chatterjee AK, Grubbs RH. ChemInform Abstract: Synthesis of Trisubstituted Alkenes via Olefin Cross-Metathesis. Cheminform. 31: no-no. DOI: 10.1002/chin.200008049  0.394
2010 MCDONALD FE, CHATTERJEE AK. ChemInform Abstract: Group VI Metal-Promoted endo-Azacyclizations via Alkyne-Derived Metal Vinylidene Carbenes. Cheminform. 29: no-no. DOI: 10.1002/CHIN.199809059  0.453
2009 Wu T, Nagle A, Sakata T, Henson K, Borboa R, Chen Z, Kuhen K, Plouffe D, Winzeler E, Adrian F, Tuntland T, Chang J, Simerson S, Howard S, Ek J, ... ... Chatterjee AK, et al. Cell-based optimization of novel benzamides as potential antimalarial leads. Bioorganic & Medicinal Chemistry Letters. 19: 6970-4. PMID 19879133 DOI: 10.1016/J.Bmcl.2009.10.050  0.428
2008 Alper PB, Marsilje TH, Mutnick D, Lu W, Chatterjee A, Roberts MJ, He Y, Karanewsky DS, Chow D, Lao J, Gerken A, Tuntland T, Liu B, Chang J, Gordon P, et al. Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor. Bioorganic & Medicinal Chemistry Letters. 18: 5255-8. PMID 18778936 DOI: 10.1016/J.Bmcl.2008.08.068  0.326
2008 Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrián F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proceedings of the National Academy of Sciences of the United States of America. 105: 9059-64. PMID 18579783 DOI: 10.1073/Pnas.0802982105  0.601
2008 Kato N, Sakata T, Breton G, Le Roch KG, Nagle A, Andersen C, Bursulaya B, Henson K, Johnson J, Kumar KA, Marr F, Mason D, McNamara C, Plouffe D, Ramachandran V, ... ... Chatterjee A, et al. Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nature Chemical Biology. 4: 347-56. PMID 18454143 DOI: 10.1038/Nchembio.87  0.547
2007 Chatterjee AK, Liu H, Tully DC, Guo J, Epple R, Russo R, Williams J, Roberts M, Tuntland T, Chang J, Gordon P, Hollenbeck T, Tumanut C, Li J, Harris JL. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S. Bioorganic & Medicinal Chemistry Letters. 17: 2899-903. PMID 17382545 DOI: 10.1016/J.Bmcl.2007.02.049  0.324
2006 Tully DC, Liu H, Chatterjee AK, Alper PB, Williams JA, Roberts MJ, Mutnick D, Woodmansee DH, Hollenbeck T, Gordon P, Chang J, Tuntland T, Tumanut C, Li J, Harris JL, et al. Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 5107-11. PMID 16876407 DOI: 10.1016/J.Bmcl.2006.07.032  0.33
2006 Tully DC, Liu H, Chatterjee AK, Alper PB, Epple R, Williams JA, Roberts MJ, Woodmansee DH, Masick BT, Tumanut C, Li J, Spraggon G, Hornsby M, Chang J, Tuntland T, et al. Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers. Bioorganic & Medicinal Chemistry Letters. 16: 5112-7. PMID 16876402 DOI: 10.1016/J.Bmcl.2006.07.033  0.326
2006 Tully DC, Liu H, Alper PB, Chatterjee AK, Epple R, Roberts MJ, Williams JA, Nguyen KT, Woodmansee DH, Tumanut C, Li J, Spraggon G, Chang J, Tuntland T, Harris JL, et al. Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3. Bioorganic & Medicinal Chemistry Letters. 16: 1975-80. PMID 16446091 DOI: 10.1016/J.Bmcl.2005.12.095  0.312
2006 Alper PB, Liu H, Chatterjee AK, Nguyen KT, Tully DC, Tumanut C, Li J, Harris JL, Tuntland T, Chang J, Gordon P, Hollenbeck T, Karanewsky DS. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl. Bioorganic & Medicinal Chemistry Letters. 16: 1486-90. PMID 16412634 DOI: 10.1016/J.Bmcl.2005.12.056  0.316
2003 Chatterjee AK, Choi TL, Sanders DP, Grubbs RH. A general model for selectivity in olefin cross metathesis. Journal of the American Chemical Society. 125: 11360-70. PMID 16220959 DOI: 10.1021/Ja0214882  0.721
2003 Chatterjee AK, Toste FD, Goldberg SD, Grubbs RH. Synthesis of coumarins by ring-closing metathesis Pure and Applied Chemistry. 75: 421-425. DOI: 10.1351/Pac200375040421  0.678
2003 Chatterjee AK, Grubbs RH. Formal Vinyl C-H Activation and Allylic Oxidation by Olefin Metathesis. Cheminform. 34: no-no. DOI: 10.1002/chin.200301054  0.314
2002 Chatterjee AK, Grubbs RH. Formal vinyl C[bond]H activation and allylic oxidation by olefin metathesis. Angewandte Chemie (International Ed. in English). 41: 3171-4. PMID 12207379 DOI: 10.1002/1521-3773(20020902)41:17<3171::Aid-Anie3171>3.0.Co;2-O  0.396
2002 Chatterjee AK, Sanders DP, Grubbs RH. Synthesis of symmetrical trisubstituted olefins by cross metathesis. Organic Letters. 4: 1939-42. PMID 12027652 DOI: 10.1021/Ol0259793  0.625
2002 Toste FD, Chatterjee AK, Grubbs RH. Functional group diversity by ruthenium-catalyzed olefin cross-metathesis Pure and Applied Chemistry. 74: 7-10. DOI: 10.1351/Pac200274010007  0.579
2002 Chatterjee AK, Toste FD, Choi TL, Grubbs RH. Ruthenium-catalyzed olefin cross metathesis of styrenes as an alternative to the Heck and cross-coupling reactions Advanced Synthesis and Catalysis. 344: 634-637. DOI: 10.1002/1615-4169(200208)344:6/7<634::Aid-Adsc634>3.0.Co;2-K  0.691
2001 Choi TL, Lee CW, Chatterjee AK, Grubbs RH. Olefin metathesis involving ruthenium enoic carbene complexes. Journal of the American Chemical Society. 123: 10417-8. PMID 11604005 DOI: 10.1021/Ja016386A  0.628
2001 Choi TL, Chatterjee AK, Grubbs RH. Synthesis of alpha,beta-Unsaturated Amides by Olefin Cross-Metathesis The authors would like to thank the National Institutes of Health for generous support of this research, and D. Benitez, C. Bielawski, Dr. S. D. Goldberg, Dr. C. W. Lee, J. P. Morgan, and M. S. Sanford for helpful discussions. Angewandte Chemie (International Ed. in English). 40: 1277-1279. PMID 11301449 DOI: 10.1002/1521-3773(20010401)40:7<1277::Aid-Anie1277>3.0.Co;2-E  0.599
2001 Chatterjee AK, Choi T, Grubbs RH. Synthesis of Vinyl- and Allylphosphonates by Olefin Cross-Metathesis Synlett. 2001: 1034-1037. DOI: 10.1055/S-2001-14654  0.637
2000 Chatterjee AK, Morgan JP, Scholl M, Grubbs RH. Synthesis of functionalized olefins by cross and ring-closing metatheses [7] Journal of the American Chemical Society. 122: 3783-3784. DOI: 10.1021/Ja9939744  0.642
2000 Blackwell HE, O'Leary DJ, Chatterjee AK, Washenfelder RA, Bussmann DA, Grubbs RH. New approaches to olefin cross-metathesis Journal of the American Chemical Society. 122: 58-71. DOI: 10.1021/Ja993063U  0.634
1999 Chatterjee AK, Grubbs RH. Synthesis of trisubstituted alkenes via olefin cross-metathesis. Organic Letters. 1: 1751-3. PMID 10836036 DOI: 10.1021/Ol991023P  0.455
1997 McDonald FE, Chatterjee AK. Group VI metal-promoted endo-azacyclizations via alkyne-derived metal vinylidene carbenes Tetrahedron Letters. 38: 7687-7690. DOI: 10.1016/S0040-4039(97)10006-5  0.543
1995 McDonald FE, Schultz CC, Chatterjee AK. Novel Synthesis of .alpha.-Stannyl Vinyl Ethers from Catalytic and Stoichiometric Fischer Carbene Anions Organometallics. 14: 3628-3629. DOI: 10.1021/Om00008A008  0.546
Show low-probability matches.